Related Experiment Video
Updated: Feb 11, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism
Vanessa Zaiatz-Bittencourt1, David K Finlay2,3, Clair M Gardiner2
1School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; and.
Abstract:
Cytokines stimulate rapid metabolic changes in human NK cells, including increases in both glycolysis and oxidative phosphorylation pathways. However, how these are subsequently regulated is not known. In this study, we demonstrate that TGF-β can inhibit many of these metabolic changes, including oxidative phosphorylation, glycolytic capacity, and respiratory capacity. TGF-β also inhibited cytokine-induced expression of the transferrin nutrient receptor CD71. In contrast to a recent report on murine NK cells, TGF-β-mediated suppression of these metabolic responses did not involve the inhibition of the metabolic regulator mTORC1. Inhibition of the canonical TGF-β signaling pathway was able to restore almost all metabolic and functional responses that were inhibited by TGF-β. These data suggest that pharmacological inhibition of TGF-β could provide a metabolic advantage to NK cells that is likely to result in improved functional responses. This has important implications for NK cell-based cancer immunotherapies.
Insights
Transforming growth factor-beta (TGF-β) inhibits key metabolic pathways in human natural killer (NK) cells. Inhibiting TGF-β signaling may enhance NK cell metabolism and function for cancer immunotherapy.
Area of Science:
- Immunology
- Cell Metabolism
- Cancer Immunotherapy
Background:
- Cytokines rapidly alter human natural killer (NK) cell metabolism, enhancing glycolysis and oxidative phosphorylation.
- The subsequent regulation of these cytokine-induced metabolic changes in NK cells remains largely unknown.
Purpose of the Study:
- To investigate the regulatory role of transforming growth factor-beta (TGF-β) on human NK cell metabolism.
- To determine the impact of TGF-β on NK cell metabolic pathways and nutrient receptor expression.
- To explore the therapeutic potential of targeting TGF-β signaling for enhancing NK cell-based immunotherapies.
Main Methods:
- Treatment of human NK cells with TGF-β and/or cytokines.
- Assessment of metabolic parameters including oxidative phosphorylation, glycolytic capacity, and respiratory capacity.
- Analysis of transferrin receptor CD71 expression.
- Evaluation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
- Inhibition of the canonical TGF-β signaling pathway.
Main Results:
- TGF-β significantly inhibited cytokine-induced oxidative phosphorylation, glycolytic capacity, and respiratory capacity in human NK cells.
- TGF-β suppressed the expression of the nutrient receptor CD71.
- Unlike in murine NK cells, TGF-β did not inhibit mTORC1 signaling in human NK cells.
- Inhibition of the canonical TGF-β signaling pathway restored NK cell metabolic and functional responses.
Conclusions:
- TGF-β acts as a negative regulator of human NK cell metabolism and function.
- Targeting TGF-β signaling, independent of mTORC1, offers a potential strategy to enhance NK cell metabolic fitness.
- Pharmacological inhibition of TGF-β may improve NK cell-based cancer immunotherapies by boosting their metabolic and functional capabilities.
Related Concept Videos
TGF - β Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

